Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
about
Inflammatory and oxidative stress in rotavirus infectionModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsAvian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitorCyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agentsAdjunctive therapies and immunomodulating agents for severe influenza.Networks of Host Factors that Interact with NS1 Protein of Influenza A VirusHow to approach and treat viral infections in ICU patientsTropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ culturesDifferential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies.Human Intervention Study to Assess the Effects of Supplementation with Olive Leaf Extract on Peripheral Blood Mononuclear Cell Gene Expression.Antiviral strategies against influenza virus: towards new therapeutic approaches.Targeting eicosanoid pathways in the development of novel anti-influenza drugs.Influenza A viruses suppress cyclooxygenase-2 expression by affecting its mRNA stability.H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Transcriptome Analysis Reveals Dynamic Gene Expression Profiles in Porcine Alveolar Macrophages in Response to the Chinese Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus.HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer.Feline calicivirus- and murine norovirus-induced COX-2/PGE2 signaling pathway has proviral effectsAdvancements in Host-Based Interventions for Influenza TreatmentHormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy
P2860
Q26749801-43458FF3-8A0F-4018-BBE9-91C7DB9DE194Q26800158-DECBA622-E4A2-4B44-9E4A-DCB87FC81DAEQ28543086-AD076060-C6AF-4114-8997-5D2B9EFA3D88Q28974151-9A8F79D6-30F7-4A42-8148-08FF8D5024F1Q30355446-9EDB04BC-A655-4FD7-ABD4-49DE53B0D8FFQ30388331-BB194FE7-F9BE-4B63-848D-6C13C06926BFQ34894660-BB487A67-B792-48A1-9CA5-2CB5C298B7C8Q36911737-1D229FB0-4D1C-4300-A9AC-AB491DB78C6FQ37138984-ED759053-D5D3-41C8-9523-18B418319197Q37534624-163C5A76-C646-45CB-A1FA-528699EB06D4Q38202012-3A6F7D89-0DB6-4B7D-A839-6EAA19C9BF87Q38255645-E31134B5-3E32-4107-8D84-10E9785118C9Q39707624-D25A2BC7-92F5-43DC-9158-0FB534DA2905Q45324226-FCB961E5-D8AE-4B3A-BA34-CEC5645CE98DQ47554935-B332B2C6-2B56-4F07-9682-7FC9FEEEA0B0Q55247919-29741260-CFEC-4D4F-8808-7BD9EDB03DB8Q55365198-57B34FA9-53B5-4284-87A9-51387373100FQ56396401-23C437F3-52EC-4830-BFBE-9A21CE3A6D5EQ56996774-0BF48E82-4ECB-4695-9BC9-AB2E2436FF40Q58699144-CCCD761F-7278-4CAB-98D4-43239558F4BC
P2860
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@en
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@nl
type
label
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@en
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@nl
prefLabel
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@en
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@nl
P2093
P1433
P1476
Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
@en
P2093
Suki M Y Lee
Timothy K W Cheung
P304
P356
10.1016/J.ANTIVIRAL.2011.07.011
P50
P577
2011-07-21T00:00:00Z